Horst Zincke - Concepedia

Author

Horst Zincke

Mayo Clinic

Also Known As

H ZINCKE, H Zincke, H. ZINCKE, H. Zincke, HORST ZINCKE, Horst Zincke, Horst* Zincke, Horst. Zincke

559

Publications

38.1K

Citations

107

H-Index

125

Concepts

All Affiliations

Mayo Clinic Mayo Clinic in Arizona Mayo Clinic in Florida WinnMed Indiana University – Purdue University Indianapolis

About

Horst Zincke is an author at Mayo Clinic specializing in medicine, urology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	61	145	13.3K
2	Health Sciences	5	5	84
3	Engineering	2	2	71
4	Public Health	2	2	137
5	Anatomy	1	1	31

Horst Zincke

309

Publications

36.5K

Citations

106

H-Index

Page 1

	Year	Citations
An Outcome Prediction Model for Patients with Clear Cell Renal Cell Carcinoma Treated with Radical Nephrectomy Based on Tumor Stage, Size, Grade and Necrosis: The Ssign Score Igor Frank, Michael L. Blute, John C. Cheville, The Journal of Urology	2002	1.1K
Comparisons of Outcome and Prognostic Features Among Histologic Subtypes of Renal Cell Carcinoma John C. Cheville, Christine M. Lohse, Horst Zincke, The American Journal of Surgical Pathology UrologySurgical OncologyRcc TumorsGenitourinary CancerKidney Research	2003	1.1K
Solid Renal Tumors: An Analysis of Pathological Features Related to Tumor Size Igor Frank, Michael L. Blute, John C. Cheville, The Journal of Urology	2003	1.1K
Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up R. Houston Thompson, Susan M. Kuntz, Bradley C. Leibovich, Cancer Research Surgical OncologyRenal PathologyImmunologyImmunoeditingPathology	2006	863
Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma Bradley C. Leibovich, Michael L. Blute, John C. Cheville, Cancer	2003	807
Costimulatory B7-H1 in renal cell carcinoma patients: Indicator of tumor aggressiveness and potential therapeutic target R. Houston Thompson, Michael D. Gillett, John C. Cheville, Proceedings of the National Academy of Sciences	2004	763
Matched Comparison of Radical Nephrectomy vs Nephron-Sparing Surgery in Patients With Unilateral Renal Cell Carcinoma and a Normal Contralateral Kidney Weber Kam On Lau, Michael L. Blute, Amy L. Weaver, Mayo Clinic Proceedings UrologySurgical OncologyRenal FunctionGenitourinary CancerRenal Pathology	2000	757
Long-Term (15 Years) Results After Radical Prostatectomy For Clinically Localized (Stage T2c Or Lower) Prostate Cancer Horst Zincke, Joseph E. Oesterling, Michael L. Blute, The Journal of Urology	1994	692
The Mayo Clinic experience with surgical management, complications and outcome for patients with renal cell carcinoma and venous tumour thrombus Michael L. Blute, Bradley C. Leibovich, Christine M. Lohse, British Journal of Urology	2004	680
Nephron Sparing Surgery for Appropriately Selected Renal Cell Carcinoma Between 4 and 7 Cm Results in Outcome Similar to Radical Nephrectomy Bradley C. Leibovich, Michael L. Blute, John C. Cheville, The Journal of Urology	2004	582

Page 1